作者
Jessica R MacNeil, Lorry Rubin, Temitope Folaranmi, Ismael R Ortega-Sanchez, Manisha Patel, Stacey W Martin
发表日期
2015/10/23
期刊
Morbidity and Mortality Weekly Report
卷号
64
期号
41
页码范围
1171-1176
出版商
Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services
简介
Methods
The ACIP Meningococcal Vaccines Work Group reviewed the immunogenicity and safety data from seven clinical trials of MenB-FHbp (2–5)(Pfizer, unpublished data) and five clinical trials of MenB-4C (6–10) during monthly telecon ferences. The work group evaluated the available published and unpublished data and evidence regarding meningococcal disease epidemiology in the United States, carriage, costeffectiveness, immunogenicity, and safety. Based on a literature search and consultation with the manufacturers, these studies represent all known clinical trials and evidence for these two vaccines. A summary of the data reviewed and Work Group discussions was presented to ACIP, and recommendations for use of MenB vaccines in adolescents and young adults were approved by ACIP at its June 24, 2015, meeting (meeting minutes are available at http://www. cdc. gov/vaccines/acip/meetings …
引用总数
20162017201820192020202120222023202427493727331812107